Combining immunotherapy and epidermal growth factor receptor kinase inhibitors: worth the risk?.
Citation: Annals of Translational Medicine. 7(Suppl 3):S76, 2019 Jul.PMID: 31576285Institution: Washington Cancer InstituteForm of publication: Journal ArticleMedline article type(s): Comment | EditorialSubject headings: IN PROCESS -- NOT YET INDEXEDYear: 2019ISSN:- 2305-5839
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | 31576285 | Available | 31576285 |
English